Extended Spectrum Beta-Lactamase (ESBL)
DOI:
https://doi.org/10.30649/obj.v1i1.3Keywords:
antibiotic(s), resistance, ESBLAbstract
Antibiotics have been widely used today. Use of antibiotics is also often used in mass
and not in accordance with the indication, among others, in a particular case of fish
poisoning on the beach, often the treatment is given antibiotics without clearly
indication. Use of antibiotics are excessive and not in accordance with the clinical, can
cause resistance to these antibiotics
One of the antibiotics used is a beta-lactam antibiotic, that works inhibits cell walls.
The inappropriate use of beta-lactam antibiotics can lead to resistance to these
antibiotics. Resistance to beta-lactam can occur at various levels. One of the resistances
can occur is resistance to Extended Spectrum Broad Lactamase (ESBL)
Extended spectrum beta-lactamase is an enzyme that has the ability to hydrolyze
penicillin-type antibiotics, first-generation cephalosporins, two, and three as well as
monobactam groups and cause resistance throughout the antibiotic.
ESBL is produced by many Enterobactericeae (especially Escherichia coli) and
Klebsiella pneumoniae. Enterobacteriaceae has 3 resistance patterns caused by broadspectrum beta-lactamase, beta-lactamase-resistant inhibitors (TEM derivatives),
excessive cephalosporinase. ESBL can be difficult to detect because ESBL has
differentiatedactivity to various cephalosporins
ESBL can be detected in clinical microbiology (phenotypic) and molecular detection
(genotypic)
References
Bradford, P., 2001. Extended-spectrum β-lactamase in the 21st century:
Characterization, Epidemiology, and Detection of this Important Resistance
Threat.. Clinical Microbiology, 30(4), pp. 933-951.
Caroll KC; Glanz BD; Borek AP; Bhally HS; Henciak S; Flayhart D, 2006. Evaluation
of The BD Phoenix Automated Microbiology System for Identification and
Antimicrobial Susceptibility Testing. Journal of Microbiology, 44(10), pp.
-3509.
Deschen CT; Shymassre D; Luna A; Ranabial Pal; Takhelimban SK, 2009. Extended
spectrum β-lactamase detection in gram negatif bactery of nosocomial origin.
Journal Global Infection Disease, 1(2), pp. 87-92.
Drieue L; Brossier F; Sougakoff W; Jarlier V, 2008. Phenotypic detection of extendedspectrum β-lactamase production in Enterobabteriaceae: review and bench
guide. Clinical Microbiology Infection Journal , 14(1), pp. 90-103.
Forbes BA ; Weissfeld AS; Sahm DF, 2007. Laboratory Methods and Strategies for
Antimicrobial Susceptibility Testing . In: Bailey & Scotts's Diagnostic
Microbiology . Philladelpia: Elsevier, pp. 187-213.
www.wiley.com
Isenberg, H., 1998. Essential Prosedures for Clinical Microbiology. Washington: ASM
Press.
Jean B Patel; Melvin P Weinstein; George M Polipous, 2017. Screening and
Confirmatory Test for ESBL. In: M100-S22. Performance Standards for
Antimicrobial Susceptibility Testing. 27 ed. Wayne: Clinical and Laboratory
Standard Institute.
Lalitha, M., 2017. Manual on Antimicrobial Susceptibility Testing.
www.ijmm.org/document/antimicrobial.com. [Online]
[Accessed 1 Agustus 2017].
Patologi Klinik RSUD Dr Soetomo -FK UNAIR 2010. Semiloka Mikrobiologi.
Rupp ME; Fey PD, 2003. Extended Spectrum β-lactamase (ESBL)- Producing
Enterobacteriaceae Consideration for Diagnosis, Prevention and Drug
Treatmment. DIagnosis Microbiology Infection Diseases, 63(4), pp. 353-365.
Thomson KE; Cornish NE; Hong, Hemrick Kim; Herdt C; Mollan ES., 2007.
Comparison of Phoenix and Vitek 2 Extended-spectrum β-lactamase Detection
Tests for analysis of Escherichia coli and Klebsiella Isolates with WellCharacterized β-lactamases, Orlando : ASM.
Thomson KE; Molland ES., n.d. Comparison of Phoenix and Vitek 2 ESBL
Confirmatory Tests against E.coli and Klebsiella Isolates with wellcharacterized β-lactamases. As presented at the 106 th General Meeting of the
American Society for Microbiology (ASM) O.
Turng B; Votta M; Turner D, Pollit J; Callihan D; Wullf S; Wiles T , 2012. Detection
of Extended Spectrum Beta-lactamase Among Enterobacteriaceae Using
PhoenixTM Automated Microbiology System with BDXpertTM System, San
Diego: Interscience Conference on Antimicrobial Agents and Chemotherapy
(ICAC).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2018 Oceana Biomedicina Journal

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.